HSBC Holdings Plc this month signaled internal aspirations to elevate its market capitalization from just above £200 billion to £300 billion over the next three years. The bank’s new strategy, announced in an internal memo dated January 10, 2026, outlines a £5 billion cost-reduction programme targeting 10,000 roles globally, along with the exit from 15 non-core markets by mid-2027. CEO Noel Quinn has set a return on equity goal of at least 9 percent by 2028, up from 6.5 percent in 2025, driven by tighter expense control, higher-margin wealth management services in Asia, and continued growth in sustainable finance. This valuation ambition assumes an increase in net interest margin to 2.0 percent over the next two years, compared with 1.65 percent in the first half of 2025.

On January 20, HSBC strategist Ishan Jain upgraded peer Albemarle Corp. to a Buy recommendation from Hold, citing improved spodumene supply forecasts and stronger contract pricing in the lithium segment. The move, intended for institutional clients, underscored HSBC’s growing influence in commodity-sector analysis. Jain’s report projects a 25 percent increase in Albemarle’s EBITDA by 2027, driven by a forecasted 35 percent rise in lithium hydroxide volumes for EV batteries and new data-center storage applications. The upgrade sparked a near 10 percent rally in Sigma Lithium shares on the same day, illustrating HSBC’s capacity to shape investor sentiment across related markets.